Workflow
Kidswant Children Products (301078)
icon
Search documents
零售股强势,永辉超市、步步高等多股涨停
Ge Long Hui· 2025-12-10 04:05
12月10日,A股市场零售股上午盘中表现强势,截至半日收涨,永辉超市、中央商场、茂业商业、东百 集团、汇嘉时代、步步高涨停,中百集团涨超7%,孩子王涨超5%。 责任编辑:栎树 消息面上,全国零售业创新发展大会9日至10日在北京举行。商务部副部长盛秋平在会上表示,"十五 五"时期,要把零售业作为培育完整内需体系、做强国内大循环的关键着力点,推动行业转向品质驱 动、服务驱动,实现高质量发展。 | 代码 | 名称 | | 涨幅% ↓ | 总市值 | 年初至今涨幅%。 | | --- | --- | --- | --- | --- | --- | | 601933 | 永辉超市 | 1 | 10.11 | 475亿 | -17.51 | | 600280 | 中央商场 | - | 10.10 | 50.44亿 | 8.76 | | 600828 | 茂业商业 | 1 | 10.03 | 123亿 | 63.16 | | 600693 | 东百集团 | 1 | 9.98 | 118亿 | 96.33 | | 603101 | 汇嘉时代 | | 9.97 | 49.82亿 | 14.28 | | 002251 | 步步高 ...
水银体温计禁产在即 线上店开始断货 客服称“购买的顾客增多”!生产企业:肯定遵守规定 要全面转型
Mei Ri Jing Ji Xin Wen· 2025-12-09 16:54
12月9日,"水银体温计血压计明年起禁产"登上热搜。 鱼跃医疗证券部相关人士表示,相关产品在公司业务中的体量是非常小的,目前主要生产电子产品。 九安医疗证券部相关人士则表示,公司不是传统的体温计生产厂商,公司额温枪基于红外技术,即便是有水银体温计、血压计相关产品,也是很 少的,对公司影响可以忽略不计,公司医疗器械业务最大的收入来源是试剂盒,主要市场在美国。 据蓝鲸新闻报道,记者观察到,在电商平台上,多个店铺的水银温度计出现断货,商品链接中可以下单的多为玻璃温度计、电子温度计。多个店 铺客服称,最近几日购买水银温度计的顾客明显增多,如果无法下单就表示已经无货,是否补货也还暂时不清楚。 另据大皖新闻报道,12月9日,记者在安徽宣城走访了多家药店。当记者询问是否有"水银体温计"销售时,多位药店工作人员表示,"听说明年开 始就不准生产了。"作为行业内人士,她们关注到了相关的信息。 "最近流感多,之前的都卖完了,暂时还没进到货。"一家连锁药店工作人员表示,目前店里没有水银体温计卖,但有电子体温计和红外体温计销 售。在货架上,记者看到多款电子体温计和红外体温计,不少产品价格超百元,远高于单价不到10元的水银体温计。 在另 ...
孩子王:公司将在定期报告中披露相关股东信息和人数
Zheng Quan Ri Bao Wang· 2025-12-09 09:12
证券日报网讯12月9日,孩子王(301078)在互动平台回答投资者提问时表示,为保证所有投资者平等 获悉公司信息,公司会在各定期报告中披露相关股东信息和人数。 ...
孩子王:公司目前经营一切正常
Zheng Quan Ri Bao· 2025-12-08 11:36
(文章来源:证券日报) 证券日报网讯 12月8日,孩子王在互动平台回答投资者提问时表示,公司目前经营一切正常,公司严格 按照规定履行信息披露义务,不存在应披露而未披露的重大事项,无财务造假、重大违规情形等情形。 ...
化妆品医美行业周报:11月抖音表现符合预期,双12国货积极备战-20251207
Investment Rating - The report maintains a "Positive" outlook on the cosmetics and medical beauty industry, despite recent underperformance compared to the market [4][5]. Core Insights - The cosmetics and medical beauty sector has shown weaker performance, with the Shenwan Beauty Care Index declining by 2.0% from November 28 to December 5, 2025, underperforming the market [4][5]. - Douyin's performance in November met expectations, with domestic brands preparing actively for the upcoming Double 12 sales event, indicating a strong competitive landscape for domestic products [4][10]. - The report highlights the leading market share of Minoxidil products, particularly from Mandi International, which has established itself as a top brand in the hair growth sector [11][12]. Summary by Sections Industry Performance - The Shenwan Cosmetics Index fell by 2.2%, while the Shenwan Personal Care Index also dropped by 2.0%, both underperforming against the Shenwan A Index [4][5]. - The top-performing stocks in the sector included Juzhibio (+5.9%) and Hongmian Co. (+3.5%), while the worst performers were Kelao Co. (-7.6%) and Baiya Co. (-4.8%) [6]. Key Market Developments - Mandi International has dominated the Minoxidil market, achieving a revenue growth from 982 million yuan in 2022 to approximately 1.455 billion yuan in 2024, with a CAGR of 21.7% [12][13]. - The company has maintained a leading position in the market for ten consecutive years, with a market share of about 57% in the hair loss treatment sector and 71% in the Minoxidil product market as of 2024 [12][14]. E-commerce Insights - In November 2025, Douyin's domestic brand GMV showed significant growth, with brands like Han Shu and New Page experiencing double-digit increases [15][18]. - The overall retail sales of cosmetics in October 2025 grew by 9.6%, driven by the Double 11 shopping festival, indicating a robust recovery in consumer spending [18][20]. Company Announcements - Lin Qingxuan updated its IPO prospectus for the Hong Kong market, reporting a revenue of 1.052 billion yuan in the first half of 2025, a year-on-year increase of 98.3% [22][19]. - The company plans to expand its research and development team and explore international markets in Southeast Asia [22][19]. Market Trends - The Chinese consumer healthcare market is projected to grow from 9.313 billion yuan in 2018 to 16.420 billion yuan in 2024, with a CAGR of 9.9% [13]. - The report emphasizes the increasing market share of domestic brands in the skincare sector, with a notable rise in the competitive landscape against international brands [24].
孩子王:公司首款自研AI智能陪伴玩偶玩具“啊贝贝”已经上市
(编辑 楚丽君) 证券日报网讯 12月5日,孩子王在互动平台回答投资者提问时表示,公司首款自研AI智能陪伴玩偶玩 具"啊贝贝"已经上市,销售情况良好,具体的销售数据可关注公司发布的定期报告;其次,公司全渠道 已引入多款AI产品,涉及早教玩具、故事机器人、下棋学练机器人等;最后,公司将持续研发升级AI 产品,探索推进渠道专款或联名款,搭建完善AI产品矩阵,充分满足亲子家庭需求。鉴于公司AI产品 尚处于初步发展阶段,在公司业务中占比较小,对公司业绩不构成重大影响,敬请投资者谨慎决策,注 意投资风险。 ...
孩子王:公司全渠道已引入多款AI产品,涉及早教玩具、故事机器人、下棋学练机器人等
Ge Long Hui· 2025-12-05 06:55
格隆汇12月5日丨孩子王(301078.SZ)在互动平台表示,首先,公司首款自研AI智能陪伴玩偶玩具"啊贝 贝"已经上市,销售情况良好,具体的销售数据可关注公司发布的定期报告;其次,公司全渠道已引入 多款AI产品,涉及早教玩具、故事机器人、下棋学练机器人等;最后,公司将持续研发升级AI产品, 探索推进渠道专款或联名款,搭建完善AI产品矩阵,充分满足亲子家庭需求。鉴于公司AI产品尚处于 初步发展阶段,在公司业务中占比较小,对公司业绩不构成重大影响。 ...
孩子王(301078.SZ):公司全渠道已引入多款AI产品,涉及早教玩具、故事机器人、下棋学练机器人等
Ge Long Hui· 2025-12-05 06:53
(原标题:孩子王(301078.SZ):公司全渠道已引入多款AI产品,涉及早教玩具、故事机器人、下棋学练机器人等) 格隆汇12月5日丨孩子王(301078.SZ)在互动平台表示,首先,公司首款自研AI智能陪伴玩偶玩具"啊贝贝"已经上市,销售情况良好,具体的销售 数据可关注公司发布的定期报告;其次,公司全渠道已引入多款AI产品,涉及早教玩具、故事机器人、下棋学练机器人等;最后,公司将持续研 发升级AI产品,探索推进渠道专款或联名款,搭建完善AI产品矩阵,充分满足亲子家庭需求。鉴于公司AI产品尚处于初步发展阶段,在公司业务 中占比较小,对公司业绩不构成重大影响。 ...
孩子王:公司AI产品尚处于初步发展阶段,在公司业务中占比较小
Mei Ri Jing Ji Xin Wen· 2025-12-05 05:03
孩子王(301078.SZ)12月5日在投资者互动平台表示,公司首款自研AI智能陪伴玩偶玩具"啊贝贝"已经 价上市。后续,公司将持续研发升级AI玩具产品,以充分发挥公司的数智化、全渠道等方面优势。鉴 于公司AI产品尚处于初步发展阶段,在公司业务中占比较小,对公司业绩不构成重大影响,敬请投资 者谨慎决策,注意投资风险。 每经AI快讯,有投资者在投资者互动平台提问:孩子王有自主研发AI玩具吗? (文章来源:每日经济新闻) ...
孩子王涨2.10%,成交额1.33亿元,主力资金净流入1530.33万元
Xin Lang Zheng Quan· 2025-12-01 03:23
Group 1 - The stock price of Kid King increased by 2.10% on December 1, reaching 10.23 CNY per share, with a total market capitalization of 12.902 billion CNY [1] - Year-to-date, Kid King’s stock price has decreased by 9.56%, with a recent 5-day increase of 2.30% and a 20-day decrease of 5.80% [2] - As of September 30, 2025, Kid King reported a revenue of 7.349 billion CNY, representing a year-on-year growth of 8.10%, and a net profit of 209 million CNY, reflecting a 59.29% increase [2] Group 2 - Kid King has a diverse revenue structure, with 88.10% from maternal and infant product sales, 6.83% from supplier services, and smaller contributions from other services [2] - The company has distributed a total of 1.87 billion CNY in dividends since its A-share listing, with 1.65 billion CNY in the last three years [3] - As of September 30, 2025, the number of shareholders increased by 51.37% to 79,000, while the average circulating shares per person decreased by 33.93% to 15,875 shares [2]